|
LIPT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.715010E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.776000E-04 |
| Normal-vs-Stage2 |
1.499780E-01 |
| Normal-vs-Stage3 |
3.176600E-03 |
| Normal-vs-Stage4 |
9.211600E-01 |
| Stage1-vs-Stage2 |
2.659600E-01 |
| Stage1-vs-Stage3 |
4.989600E-01 |
| Stage1-vs-Stage4 |
4.065800E-01 |
| Stage2-vs-Stage3 |
1.858420E-01 |
| Stage2-vs-Stage4 |
6.524000E-01 |
| Stage3-vs-Stage4 |
3.222000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.563800E-03 |
| Normal-vs-AfricanAmerican |
1.401950E-03 |
| Normal-vs-Asian |
8.263800E-01 |
| Caucasian-vs-AfricanAmerican |
5.285200E-01 |
| Caucasian-vs-Asian |
2.618200E-01 |
| AfricanAmerican-vs-Asian |
1.361020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.422900E-04 |
| Normal-vs-Female |
2.624000E-02 |
| Male-vs-Female |
1.619180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.923500E-02 |
| Normal-vs-Extreme_Weight |
3.808900E-04 |
| Normal-vs-Obese |
1.443000E-03 |
| Normal-vs-Extreme_Obese |
2.631800E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.348800E-01 |
| Normal_Weight-vs-Obese |
6.574800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.931600E-01 |
| Extreme_Weight-vs-Obese |
8.034000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.093600E-01 |
| Obese-vs-Extreme_Obese |
8.138600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.086840E-01 |
| Normal-vs-Age(41-60Yrs) |
2.351600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.406500E-04 |
| Normal-vs-Age(81-100Yrs) |
6.390600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.082400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.461200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.178500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.969210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.713900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.263160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.964600E-03 |
| Normal-VS-Type2 PRCC |
1.415300E-03 |
| Normal-VS-KIRP CIMP |
2.063800E-02 |
| Normal-VS-Unclassified PRCC |
1.175540E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.121600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.042600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.215600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.444600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.106400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.489600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.376900E-04 |
| Normal-vs-N1 |
6.208200E-01 |
| Normal-vs-N2 |
1.606580E-01 |
| N0-vs-N1 |
1.425780E-01 |
| N0-vs-N2 |
9.714800E-01 |
| N1-vs-N2 |
5.476000E-01 |
|
|
